LSI Europe

The ABCs of LSI Europe ‘25: Today’s letter of the day is F for — Fundraising Laws Many European startups are unknowingly exposing themselves to regulatory risk when raising capital. This workshop “Crossing the Line: How EU Startups Unknowingly Violate U.S. Fundraising Laws,” walked through common missteps, explained how U.S. fundraising laws apply to non-U.S. startups, and offered clear, practical guidance on how to stay compliant while still securing capital. This session featured: • Gavin Leonard MBA — CEO, MedTech Syndicates • Soyoung Park — General Partner, 1004 Venture Partners • David Uffer — Managing Director, Medtech, Trinity Life Sciences • Martin Omid A. — Managing Director, Anthro Ventures The video recording of this panel will be available in the coming weeks. Tune in each day as we recap LSI Europe ‘25 from A to Z. #LSIEurope25

The ABCs of LSI Europe ‘25: Today’s letter of the day is F for — From Innovation to Icon: How to Build a Brand and Buzz in Medtech Transforming a promising medtech venture into a high-impact, scalable company requires strategic vision, a differentiated brand, and a sharp commercial approach. In this candid workshop, three seasoned leaders shared hard-won lessons based on real-world experience from early-stage launches to high-profile exits, revealing key insights that shape growth and drive long-term success. They discussed the must-do moves to break through the noise, nail the commercial game, and build a company that investors chase, competitors fear and acquirers fight to own. This session featured:  • Paulo Simas — Managing Partner, Kadiko • Nicole Osmer — Founder and President, Health+Commerce • Colby Holtshouse — CEO, May Health The video recording of this session will be available in the coming weeks. Tune in each day as we recap LSI Europe ‘25 from A to Z. #LSIEurope25

The ABCs of LSI Europe ‘25: Today’s letter of the day is F for — Feedback Workshop This interactive session offered a unique opportunity for innovators to receive direct, real-time feedback from investors at We Venture Capital, Sectoral Asset Management, YAYA Capital, and KCK Medtech. This session was designed to help entrepreneurs build relationships, sharpen their fundraising strategies, and gain a clear view of the benchmarks investors are using to evaluate success in today’s market. This session featured:  • Gökçe Gün, MD MBA — Investment Analyst, We Venture Capital • Catherine Poulin-Filion — Principal, Sectoral Asset Management • Tiago Menezes — Investment Management, YAYA Capital • Chase Garfield — Senior Analyst, KCK Medtech The video recording of this panel will be available in the coming weeks. Tune in each day as we recap LSI Europe ‘25 from A to Z. #LSIEurope25

The ABCs of LSI Europe ‘25: Today’s letter is F — Fireside Chats At LSI Europe ‘25, four standout Fireside Chats took the stage: 1. Real World Evidence: The Evolving Landscape of Regulatory and Commercial Use This discussion explored how RWE can be applied live in the operating room, shared through secure telehealth links, and used to reshape regulatory pathways, inform clinical decisions, and strengthen commercial strategies across medtech. Featured speakers: • Henry Peck (Moderator) — Chief Business Officer, LSI • Bruce Ramshaw — CMIO, Caresyntax • John McDonald PhD — Senior Director Global Clinical Evidence Generation, Clinical and Medical Affairs, Teleflex • Michael Tajima — Chief Strategy Officer, Paragonix Technologies, Inc. • Mark Slack — Chief Medical Officer, CMR Surgical 2. Unplugged Fireside Chat & Wine Tasting A candid conversation with Dr. Charles Taylor, Founder of Heartflow and Moncrief Chair in Computational Medicine at the Oden Institute & Professor of Internal Medicine at UT Austin, alongside Bill Little, EVP of Corporate Development & Strategy at Orchestra BioMed. 3. Building the Medtech Ecosystem in London This Fireside brought together perspectives from across the innovation landscape to explore how London continues to grow as a global hub for medtech. Featured Speakers: • Ben Moss — Partner, Dirt & Glory Media • Carrie Baptist — Chief Strategy Officer, Conception X • Nicolas Huber — COO, LIHE, King's College London 4. Closing Fireside Chat Andrew Chung, Founder & Managing Partner of 1955 Capital, sat down with Addie H., Executive in Residence at 1955 Capital, to close out the event with insights on global investing and the future of medtech. The video recording of these sessions will be available in the coming weeks. Tune in each day as we recap LSI Europe ‘25 from A to Z. #LSIEurope25

The ABCs of LSI Europe ‘25: Today’s letter of the day is F Here are the presenting companies who took the stage that start with the letter F: • FastnAlign — Dr Preshan Jeevaratnam • Flomics — João Curado • Fluid Biomed Inc. — John Wong Tune in each day as we recap LSI Europe ‘25 from A to Z. #LSIEurope25

The ABCs of LSI Europe ‘25: Today’s letter of the day is E for — Early-Stage Medtech Investing As capital becomes more selective and funding climates vary across regions, early-stage medtech companies must adapt to a shifting investment landscape. This panel, “The Future of Early-Stage Medtech Investing: A Global Outlook” brought together seasoned investors from across Europe and the United States to discuss how they’re navigating the current landscape, where they see opportunity, and what founders need to know to stand out in today’s market. This session featured:  • C David Adair MD, MBA, FACOG, FASH, C-EFM — Managing Partner, Co-founder, Solas BioVentures • Bibi Sattar Marques — Partner, Buenavista Equity Partners (formerly GED Capital) • Branden Rosenhan MD — Founding Partner, MedMountain Ventures • Robert Hornby - Mercia Ventures — Investment Director, Mercia Ventures • Nick Pachuda — Innovation & New Ventures, Precision Life Science Partners The video recording of this panel will be available in the coming weeks. Tune in each day as we recap LSI Europe ‘25 from A to Z. #LSIEurope25

The ABCs of LSI Europe ‘25 — The letter of the day is E for Ellenoff Grossman & Schole LLP, an LSI Europe ‘25 sponsor. Ellenoff Grossman & Schole LLP is a New York City-based law firm comprised of nearly 125 professionals, offering its clients legal services in a broad range of business-related matters. Founded in 1992, the Firm specializes in many areas of commercial law: Corporate, Securities, Mergers and Acquisitions, International Transactions, Real Estate, Broker-Dealer Regulation, Intellectual Property, Litigation, Labor, Employment, Cannabis, ERISA, Executive Compensation, Tax and Estate Planning. Thank you to Ellenoff Grossman & Schole for your unwavering commitment. Your partnership empowers us to support thousands of innovators, investors, and strategics worldwide as we work to move Medtech forward, together.

The ABCs of LSI Europe ‘25: Today’s letter of the day is E Here are the presenting companies who took the stage that start with the letter E: • EBAMed — Marina Izzo • Echopoint Medical Ltd— Antony Odell • EFA Technologies — Yoel Ezra • ElectraDx — Veronique Ameye • Emboline, Inc. — Scott Russell • Enzyre B.V. — Waander L. van Heerde • EP Solutions — Marcin Gołębicki • Epion Therapeutics — Mike Webb Tune in each day as we recap LSI Europe ‘25 from A to Z. #LSIEurope25

The ABCs of LSI Europe ‘25: Today’s letter of the day is D for — Data Data alone isn’t enough. Success comes from how it’s applied to solve real problems and inform better decisions. In this session, “Unlock Better Decisions with Data”, we heard from the entrepreneurs and investors turning raw data into actionable insights that improve clinical outcomes, streamline operations, and drive smarter business decisions across the medtech landscape. This session featured:  • David Kereiakes — Managing Partner, Windham Capital Partners • Justin Ramsaran — CEO, HealthMosaic • Hamed Hanafi — Founder and CEO, NovaResp - Respiratory AI • David Cubbin — Partner, aescuvest • Franz Bozsak — CEO, Sensome The video recording of this panel will be available in the coming weeks. Tune in each day as we recap LSI Europe ‘25 from A to Z. #LSIEurope25

The ABCs of LSI Europe ‘25: Today’s letter of the day is D for — Drugs and Devices As therapies become increasingly complex, the lines between pharmaceuticals and medical devices continue to blur. This panel, “Innovating at the Intersection of Drugs and Devices” explored how innovators and investors are approaching this convergence, the opportunities it creates for patients and markets, and the unique challenges in bringing combination products to scale. This session featured:  • Steve Pham — Strategic Advisor, ZS Associates • Dr. Hubert Birner — Managing Partner, TVM Capital Life Science • Carolina Aguilar — Co-Founder & CEO, INBRAIN Neuroelectronics • Anita Watkins — Managing Director, Rex Health Ventures The video recording of this panel will be available in the coming weeks. Tune in each day as we recap LSI Europe ‘25 from A to Z. #LSIEurope25